Cargando…
Chemotherapy-Induced Peripheral Neuropathy in Egyptian Patients: Single Institution Retrospective Analysis
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a major toxicity that requires treatment modification or cessation and worsens patients’ quality of life. Its incidence is 30–40%. Occurrence and severity depend on treatment- and patient-related factors. The symptoms are self-limiting...
Autores principales: | Gaballah, Ahmed, Shafik, Amr, Elhusseiny, Khaled, Ashraf, Mai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171376/ https://www.ncbi.nlm.nih.gov/pubmed/30139229 http://dx.doi.org/10.22034/APJCP.2018.19.8.2223 |
Ejemplares similares
-
Chemotherapy-induced peripheral neuropathy
por: Zhang, Xia, et al.
Publicado: (2017) -
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
por: Starobova, Hana, et al.
Publicado: (2017) -
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
por: Zajączkowska, Renata, et al.
Publicado: (2019) -
Acupuncture for the Management of Chemotherapy-Induced Peripheral Neuropathy
por: Visovsky, Constance
Publicado: (2012) -
Chemotherapy-Induced Peripheral Neuropathy and Changes in Cytoskeleton
por: Malacrida, Alessio, et al.
Publicado: (2019)